P3265
Poly(ethylene glycol)
average MN 400
Synonym(s):
Polyethylene glycol, PEG
Sign Into View Organizational & Contract Pricing
All Photos(1)
About This Item
Linear Formula:
H(OCH2CH2)nOH
CAS Number:
MDL number:
UNSPSC Code:
12352104
PubChem Substance ID:
NACRES:
NA.23
Recommended Products
product name
Poly(ethylene glycol), average mol wt 400
form
liquid
Quality Level
mol wt
average mol wt 400
refractive index
n/D 1.465 (20 °C)
viscosity
7.3 cSt (210 °F)
mp
4-8 °C
solubility
water: 100 mg/mL
density
1.1254 g/cm3 at 20 °C
1.0930 g/cm3 at 60 °C
SMILES string
C(CO)O
InChI
1S/C2H6O2/c3-1-2-4/h3-4H,1-2H2
InChI key
LYCAIKOWRPUZTN-UHFFFAOYSA-N
Looking for similar products? Visit Product Comparison Guide
General description
Poly(ethylene glycol) (PEG) is an oligomer of ethylene oxide that is majorly used as a synthetic polymer for its unique properties which include low cost, biocompatibility, and hydrophilicity. It can be used in the production of biomedical hydrogels.
Application
PEG has a variety of biomedical applications, applications in energy storage and drug delivery.
Storage Class Code
10 - Combustible liquids
WGK
WGK 1
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable
Personal Protective Equipment
dust mask type N95 (US), Eyeshields, Gloves
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Customers Also Viewed
Vanessa Martínez-Francés et al.
Frontiers in pharmacology, 8, 467-467 (2017-08-10)
In Valencia Region (Spain), some wild and cultivated sages are used for medicinal purposes. Among them
Biomedical hydrogels
Biomaterials, Artificial Organs and Tissue Engineering, 107-115 (2005)
Entrapment of essential oils in hydrogels for biomedical applications
Polymeric Gels, 125-141 (2018)
Hydrogels in craniofacial tissue engineering
Biomaterials for Oral and Dental Tissue Engineering, 47-64 (2017)
Takuya Nakayama et al.
Developmental biology, 426(2), 472-486 (2016-09-07)
We describe a novel recessive and nonlethal pigmentation mutant in Xenopus tropicalis. The mutant phenotype can be initially observed in tadpoles after stage 39/40, when mutant embryos display markedly reduced pigmentation in the retina and the trunk. By tadpole stage
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service